Xylem (NYSE:XYL - Get Free Report) is projected to release its Q3 2025 results before the market opens on Tuesday, October 28th. Analysts expect Xylem to post earnings of $1.24 per share and revenue of $2.22 billion for the quarter. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS.Individuals may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 28, 2025 at 9:00 AM ET.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.09 earnings per share. On average, analysts expect Xylem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Xylem Stock Performance
NYSE:XYL opened at $146.76 on Tuesday. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The firm's fifty day simple moving average is $143.39 and its 200 day simple moving average is $131.73. The stock has a market cap of $35.72 billion, a P/E ratio of 38.12, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. Xylem has a twelve month low of $100.47 and a twelve month high of $151.16.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were issued a dividend of $0.40 per share. The ex-dividend date was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio is 41.56%.
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company's stock.
Institutional Trading of Xylem
A number of institutional investors and hedge funds have recently modified their holdings of XYL. AQR Capital Management LLC increased its holdings in shares of Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company's stock worth $3,645,000 after purchasing an additional 3,900 shares in the last quarter. NewEdge Advisors LLC increased its holdings in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company's stock worth $496,000 after purchasing an additional 132 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company's stock worth $1,037,000 after purchasing an additional 3,120 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company's stock worth $1,442,000 after purchasing an additional 5,509 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company's stock worth $154,000 after acquiring an additional 635 shares during the period. Institutional investors own 87.96% of the company's stock.
Analyst Ratings Changes
XYL has been the subject of a number of research analyst reports. Mizuho raised their target price on Xylem from $125.00 to $140.00 and gave the company a "neutral" rating in a research note on Friday, September 12th. Citigroup raised their target price on Xylem from $168.00 to $173.00 and gave the company a "buy" rating in a research note on Thursday, October 9th. TD Cowen raised their target price on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research note on Tuesday, August 26th. Stifel Nicolaus raised their target price on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Finally, Barclays initiated coverage on Xylem in a research note on Friday, September 19th. They issued an "overweight" rating and a $165.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Xylem presently has an average rating of "Moderate Buy" and an average target price of $154.67.
Get Our Latest Analysis on Xylem
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.